INSIGHT | Washington reopens Zambia credit window as relationship shifts from aid tensions to strategic business
Something is moving in Zambia’s relationship with the United States. After a period marked by unusually public disagreements over health financing, stolen medicines and the terms of American assistance, Washington is again putting practical instruments behind its engagement with Lusaka. The latest signal is financial: the US Export-Import Bank has reopened short-term support for eligible private-sector transactions involving Zambia.
The change took effect under EXIM Bank’s revised Country Limitation Schedule on July 30. Zambia is now open for private-sector support on transactions of up to one year, while medium and longer-term cover remains unavailable under the ordinary country schedule.
In practical terms, this can make it easier for qualifying Zambian companies to buy American equipment, machinery, technology and other goods. EXIM does not simply hand money to Zambian businesses. Its insurance and guarantee instruments reduce some of the commercial risk faced by American exporters and lenders when selling into Zambia.
That distinction matters.
If an American manufacturer wants to sell equipment to a Zambian company on credit, uncertainty over repayment can make the transaction expensive or impossible. US government-backed insurance can absorb part of this risk, potentially making exporters and financial institutions more willing to transact with credible Zambian buyers.
The decision therefore amounts to a modest reopening of a commercial door. It is not a declaration that Zambia can borrow without restriction from Washington, and it is not a new government loan facility.
EXIM’s current schedule still lists Zambia’s public sector as unavailable for ordinary support across short, medium and long maturities. Private-sector support is open only for transactions of up to one year. Longer private-sector transactions are also listed as unavailable, although EXIM can consider structures which remove or transfer country risk.
The timing is more interesting than the facility itself. US-Zambia relations have not moved in a straight line.
In May 2025, Washington announced plans to cut about $50 million a year in health assistance, citing what then-US Ambassador Michael Gonzales described as “systemic theft” of donated medicines and medical supplies. Zambia acknowledged problems in the medical supply chain and announced measures including a forensic audit.
Relations encountered another difficult period over negotiations for a much larger health agreement. The proposed arrangement involved more than $1 billion in American health support, alongside substantial Zambian co-financing. Lusaka resisted elements it believed required further negotiation in defence of national interests, while Washington publicly complained earlier this year about delays and insufficient engagement.
Those disagreements were significant. But they did not amount to a collapse of the relationship.
This week has made that increasingly clear.
US Assistant Secretary of State for African Affairs Frank Garcia travelled to Zambia for President Hakainde Hichilema’s September 1 inauguration. He also met Hichilema before the ceremony, with trade, investment, health and regional security among the subjects of engagement.
A day after the inauguration, Garcia joined Ministry of Health Permanent Secretary Dr George Sinyangwe at the University Teaching Hospital to mark the arrival of Zambia’s first US government-funded shipment of lenacapavir, the long-acting HIV prevention medicine administered twice a year. The US Embassy presented the shipment within a broader effort to help Zambia move towards a health system increasingly owned, led and sustained locally.
Now comes the EXIM opening. Viewed separately, these are administrative and programme decisions. Viewed together, they point towards a broader recalibration.
For decades, one of the strongest pillars of US influence in Zambia has been development and health assistance, particularly HIV programmes.
The emerging relationship appears to be adding another layer: trade, investment and commercial finance.
This is important because American foreign policy towards Africa increasingly connects diplomacy with economic interests. Health remains important, but critical minerals, energy, infrastructure, supply chains, technology and private investment have moved closer to the centre of Washington’s engagement with the continent.
Zambia fits unusually well into that calculation.
It is a major copper producer with ambitions to substantially increase output. It sits on the Central African Copperbelt beside the Democratic Republic of Congo, possesses other minerals important to industrial and clean-energy supply chains, and occupies a strategic position between eastern, central and southern African transport corridors.
China already has deep commercial and infrastructure interests in Zambia. American policy therefore operates in an environment where Washington is not entering an empty field.
This does not mean every US decision involving Zambia should be interpreted simply as competition with China. Zambia maintains substantial relationships with both countries and has repeatedly sought investment from multiple partners.
But the strategic environment cannot be ignored. What does EXIM’s decision mean for Zambian businesses? The immediate opportunity is narrower and more practical.
A Zambian company wanting American agricultural machinery, mining equipment, medical technology, industrial components or other eligible US products may now find a transaction easier to structure because EXIM can provide short-term risk support.
This could matter particularly for businesses unable to obtain competitive international supplier credit solely on the strength of Zambia’s domestic financing environment.
There are limits. Applications will still face credit assessment. Government backing does not remove commercial discipline. A weak company does not become bankable simply because Zambia appears on an EXIM schedule.
Nor does reopening short-term private cover automatically produce investment.
A financing window is an opportunity. Businesses still have to walk through it.
The larger question is whether Zambian firms can turn improved access to foreign equipment and technology into additional production rather than simply additional imports.
If financing helps a manufacturer increase output, a farmer improve productivity, a mine expand production or a technology company acquire equipment unavailable locally, the economic effect can extend beyond the original transaction.
If it merely increases consumption financed through short-term credit, the structural benefit is much smaller.
There is another message embedded in EXIM’s cautious structure. Washington has reopened short-term private-sector risk, not unrestricted sovereign financing.
This suggests confidence has improved enough to permit selected commercial transactions, but not enough to remove broader country-risk constraints.
Zambia’s debt history matters here. After becoming Africa’s first pandemic-era sovereign default in 2020, the country spent years restructuring external obligations. International creditors remain sensitive to any rapid return to unsustainable public borrowing.
The restrictions around public transactions therefore reinforce a familiar principle: new financing must fit Zambia’s debt-management commitments and its wider arrangements with international financial institutions.
The next phase of US-Zambia economic relations may consequently look very different from the old donor-recipient model. Washington has interests. Zambia has interests.
The United States wants markets for American companies, more resilient supply chains, strategic economic partnerships and influence in a mineral-rich part of Africa. Zambia wants capital, technology, markets, health security and investment capable of creating jobs.
Those interests can meet without being identical.
And this is perhaps the clearest way to understand what has happened after the recent diplomatic friction. The disagreements were real. The relationship survived them.
The arrival of lenacapavir shows health cooperation remains active. Garcia’s visit demonstrated continued high-level political engagement. EXIM’s revised position now introduces a tangible commercial instrument.
None of this proves a dramatic US “pivot” towards Zambia. The EXIM opening remains limited, and unresolved questions in the wider bilateral relationship should not be overlooked.
But the direction deserves attention.
Washington appears increasingly interested in a Zambia it can trade with, invest alongside and work with strategically, not simply one it assists.
For Lusaka, the opportunity is to convert that interest into productive capital without replacing dependence on aid with dependence on debt. This will be the more important measure of the relationship.
© The People’s Brief | Ollus R. Ndomu